Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Carmell Corp - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
CTCX
Nasdaq
8731
https://www.carmellrx.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Carmell Corp
Carmell Announces Successful Closing of $3.0 Million Private Placement
- Apr 11th, 2024 8:30 pm
Carmell Announces $3.0 Million Private Placement
- Apr 4th, 2024 12:30 pm
Carmell Announces Successful Closing of Axolotl Biologix Sale Transaction
- Mar 27th, 2024 1:15 pm
Carmell Sharpens Aesthetics Focus with Execution of Definitive Agreement to Sell Axolotl Biologix Subsidiary
- Mar 20th, 2024 8:39 pm
Carmell to Host Investor Webinar, “Unveiling the Secretome: On the Eve of Product Launch” Featuring Key Opinion Leaders in the Medical Aesthetics Field
- Mar 18th, 2024 7:16 pm
Carmell Announces Product Development Completed for G.L.E.E. Launch in March 2024
- Feb 26th, 2024 1:30 pm
Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors
- Nov 16th, 2023 1:30 pm
Moonshot Client Axolotl Announces Merger with Carmell Therapeutics, Elevating the Field of Regenerative Medicine
- Sep 12th, 2023 4:35 pm
Carmell Corporation Announces Completion of Post-Merger Integration with Axolotl Biologix and New Organizational Structure Aligned with Focus on Aesthetics
- Sep 5th, 2023 10:03 pm
Carmell Announces Successful Closing of Merger with Axolotl Biologix and Launch of a New Brand Identity
- Aug 9th, 2023 7:41 pm
Carmell Therapeutics Announces Merger with Axolotl Biologix, a Profitable Regenerative Medicine Company
- Jul 27th, 2023 11:00 am
Scroll